Disclosures for "Using Design Thinking to Improve a Resident’s Ability to Identify and Manage Social Determinants of Health Issues in the Outpatient Neurology Clinic"
-
Dr. Shah has nothing to disclose.
-
Dr. Esch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Esch has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Esch has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Esch has received research support from PCORI.
-
Dr. Avila has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals. Dr. Avila has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for argenx. Dr. Avila has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion Pharmaceuticals. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZeneca. Dr. Avila has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda.
-
Ms. Friedenberg has nothing to disclose.
-
An immediate family member of Dr. Cooney has received personal compensation for serving as an employee of ExpressScripts.
-
The institution of Dr. Friedenberg has received research support from AMA. The institution of Dr. Friedenberg has received research support from Geisinger Medical Center.